Platelet Aggregation Inhibitors: Clinical Trials

37 trials of Platelet Aggregation Inhibitors, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed, 10 unknown, 3 active not recruiting, 3 recruiting. 9 Not applicable, 9 Phase 4, 4 Phase 3, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable9Completed 5, Active not recruiting 1, Recruiting 1, Terminated 1, Unknown 1
Phase 49Completed 4, Unknown 3, Active not recruiting 1, Terminated 1
Phase 34Completed 2, Unknown 2
Phase 11Completed 1
Phase 21Unknown 1

Follow Platelet Aggregation Inhibitors: new trials by email Literature Review of Platelet Aggregation Inhibitors trials Research Report on Platelet Aggregation Inhibitors

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE
Antiplatelet Drug, Warfarin - Antiphospholipid Syndrome, Ischemic Stroke
Phase 4Active not recruitingSeoul National University Hospital2002024-02-202026-09-11
A Prospective muLticEnter Registry in chrONic coronARy synDrOme
Antiplatelet Agents - Coronary Artery Disease
Not yet recruitingUniversity of Roma La Sapienza10002024-01-012024-01-10
Antiplatelet Therapy for AIS Patients With Thrombocytopenia
aspirin, clopidogrel, cilostazol, and dipyridamole - Acute Ischemic Stroke, Thrombocytopenia
Not applicableUnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine12002023-09-152023-10-18
Intravenous Thrombolysis With rhTNK-tPA for Acute Non-large Vessel Occlusion in Extended Time Window
rhTNK-tPA, Antiplatelet Agents - Acute Ischemic Stroke
Phase 4CompletedXuanwu Hospital, Beijing5702023-06-022025-12-02
Effect of Anticoagulant Drug Intervention on Postoperative MALE and MACE in Patients With PAD
anticoagulant or antiplatelet drugs - Anticoagulant Drugs, Antiplatelet Drug
UnknownFirst Affiliated Hospital of Zhejiang University60002023-01-012023-05-10
Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction
Coronary computed tomography angiography, Invasive coronary angiography, Transthoracic echocardiography - Myocardial Infarction Type 2
Not applicableCompletedUniversity of Edinburgh602022-11-142024-09-19
Monitoring Antiplatelet Drugs in Cardiac Arrest Patients
Antiplatelet Drug - Cardiac Arrest, Myocardial Infarction
UnknownUniversity of Milano Bicocca602022-10-012023-02-15
Carotid Web and Stroke Registry.
Antiplatelet Drug, Anticoagulant, Endovascular - Stroke, Carotid Web
UnknownFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1002022-07-152022-08-01
Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS
Dual antiplatelet therapy, Combined antithrombotic therapy, Vitamin K antagonist standard intensity - Antiphospholipid Syndrome, Arterial Thrombosis
RecruitingMcMaster University1502022-07-012025-12-09
Type 2 Diabetes With Antiplatelet Drugs
Antiplatelet Drug - Type2 Diabetes, Antiplatelet Drugs
CompletedTabula Rasa HealthCare1734642021-09-202023-01-31
Effectiveness and Safety of Different Antithrombotic Therapy for the Treatment of Ventricular Thrombus
non-vitamin K antagonist oral anticoagulants (NOACs), vitamin K antagonists (VKAs), antiplatelet agents - Ventricular Thrombus
CompletedChina National Center for Cardiovascular Diseases1962021-08-042026-10-27
Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).
Coronary angiography, OCT imaging, Percutaneous coronary intervention (PCI): - Myocardial Infarction With Non-Obstructive Coronary Arteries
Phase 4UnknownFondazione Policlinico Universitario Agostino Gemelli IRCCS1202021-07-012024-07-26
Early-Start Antiplatelet Treatment After Neurosurgery in Patients With Spontaneous Intracerebral Hemorrhage
Antiplatelet Agents - Spontaneous Intracerebral Hemorrhage
Not applicableCompletedBeijing Tiantan Hospital2692021-05-012025-04-03
Endovascular Acute Stroke Intervention - Tandem OCclusion Trial
Carotid artery stenting, Antiplatelet Agents - Stroke, Acute, Carotid Stenosis
Not applicableRecruitingCentre hospitalier de l'Université de Montréal (CHUM)4582020-08-312026-08-14
Dapagliflozin Effect in Cognitive Impairment in Stroke Trial
Dapagliflozin 10mg Tab, Statins (Cardiovascular Agents), Platelet Antiaggregant - Stroke, Ischemic, Mild Cognitive Impairment
Phase 2 / Phase 3UnknownJaime Daniel Mondragon2702020-08-012022-10-04
Coronary Artery Ectasia in Elective Coronary Angiography : Predictors, Outcomes and Management
Antiplatelet Agents, Anticoagulants - Ectasia, Coronary Artery Disease
Not applicableCompletedAssiut University792019-12-012024-02-13
Effect of Antiplatelet Therapy on Cognition After Aneurysmal Subarachnoid Hemorrhage
Antiplatelet Drug - Aneurysmal Subarachnoid Hemorrhage
UnknownNanjing Medical University2002019-11-012020-09-14
Mild Head Injury, Antiplatelets, and Anticoagulants
direct anticoagulant, antiplatelet drugs, Dicumarols - Craniocerebral Trauma, Cerebral Hemorrhage
CompletedFondazione Policlinico Universitario Agostino Gemelli IRCCS21272019-09-272022-03-31
Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease
Edoxaban Monotherapy, Edoxaban plus Single Antiplatelet Agent - Atrial Fibrillation, Coronary Artery Disease
Phase 4CompletedGi-Byoung Nam10402019-05-142024-06-10
Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone
Sulodexide, Statin, Antiplatelet Agents - Peripheral Arterial Obstructive Disease
Phase 3UnknownAlfa Wassermann Tunisia1562019-01-312019-12-02

Showing 20 of 37. Sign in to see all of them.

Conditions studied

Coronary Artery Disease (9)  ·  Myocardial Infarction (7)  ·  Cardiovascular Diseases (5)  ·  Ischemic Stroke (5)  ·  Acute Coronary Syndrome (4)  ·  Atrial Fibrillation (4)  ·  Heart Diseases (3)  ·  Heart Failure (3)  ·  Stroke (3)  ·  Antiphospholipid Syndrome (2)  ·  Atherosclerosis (2)  ·  Carotid Stenosis (2)  ·  Coronary Disease (2)  ·  Hemorrhage (2)  ·  Metabolic Syndrome (2)

Sponsors

Fondazione Policlinico Universitario Agostino Gemelli IRCCS (2)  ·  Seoul National University Hospital (2)  ·  Alfa Wassermann Tunisia (1)  ·  Assiut University (1)  ·  Bayer (1)  ·  Beijing Anzhen Hospital (1)  ·  Beijing Jishuitan Hospital (1)  ·  Beijing Tiantan Hospital (1)  ·  Biosensors Europe SA (1)  ·  Centre hospitalier de l'Université de Montréal (CHUM) (1)  ·  China National Center for Cardiovascular Diseases (1)  ·  ECRI bv (1)  ·  First Affiliated Hospital of Zhejiang University (1)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)  ·  Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (1)

Countries

China (7)  ·  Italy (6)  ·  South Korea (5)  ·  United States (5)  ·  United Kingdom (4)  ·  Canada (3)  ·  France (3)  ·  Germany (3)  ·  Japan (3)  ·  Poland (3)  ·  Spain (3)  ·  Argentina (2)  ·  Czechia (2)  ·  Denmark (2)  ·  Hungary (2)

Top investigators

Alexandre Y Poppe, MD CM (1)  ·  Andrew Chapman, MBChB PhD (1)  ·  Cary Clark (1)  ·  Danbee Kang, PhD (1)  ·  Duk-woo Park, MD (1)  ·  E. Spitzer, Dr. (1)  ·  Elizaveta Panchenko, PhD (1)  ·  Francesco Pelliccia, MD (1)  ·  Hai Bin Shi, MD (1)  ·  Hiroshi Yamagami, MD (1)  ·  Hisao Ogawa (1)  ·  Imed Frikha, MD (1)

Results publications

PMID 17105759, PMID 19482214, PMID 20204386, PMID 21785475, PMID 21927046, PMID 21953407, PMID 22025606, PMID 23040716, PMID 23141853, PMID 24297771, PMID 28095900, PMID 28950419, PMID 29016744, PMID 29371333, PMID 29446769, PMID 29573529, PMID 30703644, PMID 30950656, PMID 31236801, PMID 31248555, PMID 31475793, PMID 31535829, PMID 32115470, PMID 32144994, PMID 32178931, PMID 32317958, PMID 32352644, PMID 32432718, PMID 32559474, PMID 32854852, PMID 33030307, PMID 33060529, PMID 33282811, PMID 33657403, PMID 33894597, PMID 34010616, PMID 34261738, PMID 34324628, PMID 34449185, PMID 34455849, PMID 34474583, PMID 34658247, PMID 34736731, PMID 34813630, PMID 35209924, PMID 35580836, PMID 35685496, PMID 35697255, PMID 35704345, PMID 35734824

NIH funding

2015 (1), R01HL082638 (1), U01HL062509 (1)